To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

AstraZeneca

Status: Completed

Conditions: Hyperlipidemias

Study type: Observational

Funder types: Industry

Identifiers

NCT00726362

NIS-CTW-CRE-2007/1

Details and patient eligibility

About

The primary objective is to survey the efficacy of various commercially available statins (a class of lipid-lowering agents, for example, rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastatin and fluvastatin) under local clinical practice in treating patients with hyperlipidemia. Surveillance data (Lipid Profile) will be collected during course of usual clinical practice or captured upon its availability.

Enrollment: 3,270 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients diagnosed with hyperlipidemia
• Patients who are just starting a statin treatment, who need to switch from current therapy to a statin medication, or who are receiving dosage adjustment of statin as judged by the physicians
• Patients who are willing to participate in this study and who sign an informed consent form

Exclusion criteria

• Pregnancy or breast feeding
• Patient are illiterate or unable to fill the questionnaire for any reason
• Patients with contraindications to the use of certain statins as needed prescribed by physicians (as per commercially available statins package insert) including the use of rosuvastatin.
• Any clinical condition which, in the opinion of the attending physician, would not allow safe administration of the study medications

Trial design

3,270 participants in 1 patient group

1

Description:

patients with hyperlipidemia newly initiating a statin; or switched from current therapy to a statin, or require dosage adjustment for statin